Acorn Capital Advisors, LLC Aadi Bioscience, Inc. Transaction History
Acorn Capital Advisors, LLC
- $185 Billion
- Q4 2024
A detailed history of Acorn Capital Advisors, LLC transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Acorn Capital Advisors, LLC holds 1,147,052 shares of AADI stock, worth $2.97 Million. This represents 1.96% of its overall portfolio holdings.
Number of Shares
1,147,052Holding current value
$2.97 Million% of portfolio
1.96%Shares
1 transactions
Others Institutions Holding AADI
# of Institutions
57Shares Held
15.6MCall Options Held
15KPut Options Held
3.1K-
Avoro Capital Advisors LLC New York, NY2.85MShares$7.38 Million0.13% of portfolio
-
Qvt Financial LP New York, NY2.31MShares$5.99 Million0.72% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2.1MShares$5.44 Million4.12% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA1.85MShares$4.79 Million8.31% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY818KShares$2.12 Million2.93% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $54.4M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...